WBI Investments’s Idexx Laboratories IDXX Stock Holding History

WBI Investments’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-562	Closed	-$380K	–	346
2025 Q4	$380K	Buy	+562	New	+$383K	0.1%	232

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBI Investments's IDXX Position: Q1 2026 in Review

WBI Investments sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 562 shares — an estimated $380K sold.

WBI Investments first reported a position in IDXX in Q4 2025 and held it in 1 quarter. The position peaked at $380K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

WBI Investments reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
WBI Investments sold 562 Idexx Laboratories shares in Q1 2026, an estimated $380K.
WBI Investments first reported a position in Idexx Laboratories in Q4 2025 and held it in 1 quarter.
WBI Investments's Idexx Laboratories position peaked at $380K in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.